Ad
AVEO Stock - AVEO Pharmaceuticals Stock Trading
About | AVEO Pharmaceuticals Inc. (NASDAQ:AVEO)
Not available
Quote | AVEO Pharmaceuticals Inc. (NASDAQ:AVEO)
| Last: | $15 |
|---|---|
| Change Percent: | 0.03% |
| Open: | $14.995 |
| Close: | $15 |
| High: | $15 |
| Low: | $14.99 |
| Volume: | 247,877 |
| Last Trade Date Time: | 01/19/2023 10:19:21 am |
News | AVEO Pharmaceuticals Inc. (NASDAQ:AVEO)
-
SEOUL, South Korea, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LG Chem, Ltd. (“LG Chem”) (KOSPI: 051910) today announced that it has completed its previously announced acquisition of AVEO Oncology (“AVEO”), a commercial stage, oncology-focused biopharmaceutical company committe...
-
Aveo Oncology ( NASDAQ: AVEO ) shareholders have approved the company's proposed acquisition by LG Chem ( OTCPK:LGCLF ). In October 2022, LG Chem ( OTCPK:LGCLF ) proposed to acquire Aveo Oncology ( AVEO ) for $15/share in an all-cash transaction with an implied equity ...
Message Board Posts | AVEO Pharmaceuticals Inc. (NASDAQ:AVEO)
| Subject | By | Source | When |
|---|---|---|---|
| znewcar1: $AVEO 42% v23,3M c14.92 f34,6M H14.95 ML7.52 gapNhold | znewcar1 | investorshangout | 10/18/2022 8:33:02 PM |
| Hows that short working out Harry? Bahahahaha!!!! | BJ_Cooper | investorshub | 10/18/2022 4:53:49 PM |
| whytestocks: $AVEO News Article - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of | whytestocks | investorshangout | 10/18/2022 2:46:03 PM |
| whytestocks: $AVEO News Article - AVEO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sa | whytestocks | investorshangout | 10/18/2022 2:05:55 PM |
| I was just kidding Harry. Im still long. | BJ_Cooper | investorshub | 10/14/2022 4:46:21 PM |
News, Short Squeeze, Breakout and More Instantly...
AVEO Pharmaceuticals Inc. Company Name:
AVEO Stock Symbol:
NASDAQ Market:
0.03% G/L:
$15 Last:
247,877 Volume:
$14.995 Open:
$15 Close:
Ad
-
SEOUL, South Korea, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LG Chem, Ltd. (“LG Chem”) (KOSPI: 051910) today announced that it has completed its previously announced acquisition of AVEO Oncology (“AVEO”), a commercial stage, oncology-focused biopharmaceutical company committe...
-
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders ...
-
BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reminds all AVEO stockholders to vote before AVEO&#x...